Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SITAGLIPTIN
- Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia
- To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated Cirrhosis
- Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.
- Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.
- Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.
- Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.
- The Impact of Sitagliptin as an Add on Therapy With Closed Loop Control in Adolescents With Diabetic Nephropathy
- Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 in Healthy Overweight/Obese Volunteers
- High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD
- Sitagliptin in Combination With Beidougen Capsule for Type 2 Diabetes
- Effect of Gemigliptin Versus Glimepiride on Cardiac Diastolic Function in Patients With Type 2 Diabetes
- Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis
- SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H)
- Comparative Bioavailability Study of Sitagliptin/Metformin 50 mg/1000 mg Tablets in Healthy Male and Female Volunteers
- Comparative Bioavailability Study of Metformin/Sitagliptin 850 mg/50 mg Tablets in Healthy Male and Female Volunteers
- Non-alcoholic Fatty Liver Disease and Its Treatment
- A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers
- A Pharmacokinetic Study of DW6012 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers
- The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes
- Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients?
- The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
- Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single Components
- A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers
- Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study
- Effects of Sitagliptin in Relatives of T1D Patients
- Semaglutide vs Sitagliptin
- Monitoring Parameters Beyond Glycemic Control: Impact of Sitagliptin on Quality of Life in Type 2 Diabetes Patients
- Sitagliptin for Prevention of aGVHD After Alternative Donor Transplatation
- Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver Transplantation
- Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and Acarbose
- Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care
- Safety and Efficacy of Antidiabetic Drugs in Recently Diagnosed Patients With Type 2 Diabetes
- Bioequivalence of Sitagliptin Phosphate/Metformin Hydrochloride Tablets in Healthy Chinese Subjects
- MAGE of Anagliptin Compared With Sitagliptin With Type 2 Diabetes Mellitus
- Effect of CPL-2009-0031 in the Treatment of Patients With Uncontrolled Type 2 Diabetes Mellitus
- Sitagliptin for the Treatment of Type 2 Diabetes
- Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver Diseases
- Sitagliptin for the Treatment of Grade 3-4 and Refractory Acute Graft-versus-host Disease
- Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study
- The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients
- Effects of Sitagliptin in Individuals With Genetically Decreased DPP4
- Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules in Type 2 Diabetes
- Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEs
- Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS Patients
- Study of Sulphonylurea Synergy With DPP4 Inhibitors
- Clinical Study on the Improvement of Diabetic Neuropathic Pain by Liraglutide
- A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 Diabetes
- Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy
- Effect of Neprilysin on Glucagon-Like Peptide-1 in Patients With Type 2 Diabetes
- GA 6: The Blood Glucose-lowering Effect of Glucose-dependent Insulinotropic Polypeptide
- Approaches To Therapy Escalation In T2D
- Drug Interaction Study Between Dorzagliatin and Sitagliptin
- Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1
- The Effects of Neprilysin on Glucagon-like Peptide-1
- A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM
- Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
- Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes Patients
- An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin
- Empagliflozin Versus Sitagliptin Therapy for Improvement of Myocardial Perfusion Reserve in Diabetic Patients With Coronary Artery Disease
- Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell
- Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome
- Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
- A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes
- Cardiovascular Effects of GLP-1 Receptor Activation
- Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and Metformin
- Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)
- Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin
- Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes
- Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes
- Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss
- Treatment of Diabetes in Patients With Systolic Heart Failure
- Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
- Evaluation of the Effect of Sitagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes
- Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
- HbA1c Variability in Type II Diabetes
- Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus
- Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.
- Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
- CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)
- CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1)
- The Effect of DPP4 Inhibitor on Vasclular Healing
- A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
- Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion
- Drug Transporter Interaction Study PHENTRA_2015_KPUK
- Sitagliptin in Non-Diabetic Patients Undergoing General Surgery
- Randomized Sitagliptin Withdrawal Study (MK-0431-845)
- Incretin Axis in Type 1 Diabetes Mellitus
- Mechanisms Underlying Predictors of Success From Obesity Surgery
- Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2)
- A Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus Receiving Sitagliptin
- Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
- DPP4 Inhibition & Beta Cell Function
- Accelerated Wound Healing in Diabetic Ulcers by Sitagliptin
- Effect of Sitagliptin on Progression of Coronary Intermediate Lesion
- The Use of DPP-4 Inhibitors in Short Bowel Syndrome
- A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection
- Effect of DPP4 Inhibition on Vasoconstriction
- A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
- Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)
- Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
- Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D
- Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842)
- Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843)
- Sitagliptin Effects on Arterial Vasculature and Inflammation in Obesity
- Tenelia Triple Combination Study
- Ipragliflozin Add-on Long-term Study in Japanese Participants With Type 2 Diabetes Mellitus on Sitagliptin (MK-0431J-849)
- Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery
- Sitagliptin Therapy and Kinetics of Inflammatory Markers
- A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With
- Sitagliptin for Reducing Inflammation and Immune Activation
- Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)
- Saxagliptin and Cardiac Structure and Function
- Efficacy and Safety of Lobeglitazone Versus Sitagliptin
- Incretin-based Drugs and Acute Pancreatitis
- Incretin-based Drugs and Pancreatic Cancer
- Saxagliptin's Effects on Microalbuminuria Improvement in Type 2 Diabetic Patients
- Incretin-based Drugs and the Risk of Heart Failure
- A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin
- Effects of DPP-4 Inhibition on Calcium and Bone Metabolism in Type 2 Diabetes Mellitus
- Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM
- Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery
- Sitagliptin and Endothelial Dysfunction
- The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion
- Add Glucokinase Activator to Target A1c
- Study on Exploring the Effect of DPP-4 Inhibitors on β-cell Function by Using the Two-step Hyperglycemic Clamp
- DPP-4 Inhibitors and Acute Myocardial Infarction:Effects on Platelet Function
- Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes
- The Role of Phosphodiesterase Inhibitors in Incretin Secretion
- Dipeptidyl Peptidase-4 Inhibition and Narrow-band Ultraviolet-B Light in Psoriasis (DINUP)
- Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 Diabetes
- Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy
- Influence of Gut Hormones on Food Intake After Roux-en-Y Gastric Bypass Surgery
- Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial
- Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop
- The Effects of Dapagliflozin on HDL Particles Subtypes and Reverse Cholesterol Transport in Type 2 Diabetic Patients
- Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes
- Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)
- Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management
- Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes
- Effects of Sitaglpitin on Endothelial Function During the OGTT in T2DM
- Sitagliptin and Brown Adipose Tissue
- Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Contr
- Effect of Linagliptin on TRL Metabolism
- Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI
- Sitagliptin and Glucagon Counterregulation
- A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes
- Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit
- Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
- Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)
- A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients
- Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine
- Correlation Between Plasma- and Endothelial DPP-4 Activity
- Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients
- Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients
- Bioavailability of BI 10773 and Sitagliptin in Healthy Male Volunteers
- Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects
- Natriuretic Effect of GLP-1in Healthy Non Obese Subjects
- Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure
- Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes
- The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome
- Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections
- A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
- Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)
- DPP-4 Inhibition, Incretins and Islet Function
- A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden
- A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
- Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
- Use of Sitagliptin to Decrease Microalbuminuria
- Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
- Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment
- Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)
- A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
- Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers
- The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes
- Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
- Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
- Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes
- Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac Surgery
- Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease
- Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes
- Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D
- A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test
- Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes
- Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes
- Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney Transplant
- Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin
- Effect of the DPP-4 Inhibitor Sitagliptin on Islet Function After Mixed Meal in Patients With Type 2 Diabetes
- Triple Therapy in Type 2 Diabetic Patients
- Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)
- Effect of Chronic Incretin-based Therapy in Cystic Fibrosis
- Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes
- Sitagliptin Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease
- Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy
- Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM
- MASTERMIND - Understanding Individual Variation in Treatment Response in Type 2 Diabetes
- Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
- Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)
- Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 Diabetes
- TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes
- Dose-finding Study of LIK066 Compared With Placebo or Sitagliptin to Evaluate Change in HbA1c in Patients With Diabetes
- Effects of Lansoprazole on Sitagliptin Glucose-lowering Ability in Healthy Males: a Randomised Crossover Study
- A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes
- Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users
- A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)
- SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
- Sitagliptin in Type I Diabetic Patients
- Treatment of Dysglycemia Using Sitagliptin in Adolescents With Cystic Fibrosis
- Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant
- A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes
- ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia
- Effect of Omeprazole on Metformin
- A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)
- Efficacy and Safety Comparative Study of Sitagliptin,Vildagliptin and Saxagliptin
- Omarigliptin (MK-3102) Clinical Trial - Placebo- and Sitagliptin-Controlled Monotherapy Study in Japanese Patients With Type 2 Diabetes Mellitus (MK-3102-020)
- A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)
- Effect of DPP4 Inhibition on Growth Hormone Secretion
- Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart Function
- A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)
- Study of Comparing the Different Effect of DPP-4 Inhibitors and Sulfonylurea by Using "Biphase-Hyperglycemic Clamp"
- Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
- Treatment With Sitagliptin in Non-obese Japanese Patients With Type 2 Diabetes Mellitus
- Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes
- Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763
- Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes
- Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes
- Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans
- A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)
- A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)
- DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients
- A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)
- A Pilot Study Evaluating Safety of Sitagliptin Combined With Peg-IFN Alfa-2a + Ribavirin in Chronic Hepatitis C Patients
- A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)
- Effectiveness of Sitagliptin for HIV Insulin Resistance and Inflammation
- Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
- Effect of Saxagliptin Treatment on Myocardial Fat Content, and Monocyte Inflammation
- Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136)
- Sitagliptin Dose Determination Study
- Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone
- Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin
- Treatment of Diabetes After Gastric Bypass With Sitagliptin
- Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients
- Effect of Sitagliptin on Short-Term Metabolic Dysregulation of Oral Glucocorticoid Therapy
- Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
- A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)
- Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes
- A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)
- Effects of Different Early Intensive Therapies on Long-term β-cell Function
- Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260)
- A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes
- A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes
- Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus
- A Study to Evaluate the Pharmacodynamic Effects of Single-Dose Co-Administration of LX4211 With Januvia® in Type 2 Diabetics
- Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin
- Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes Mellitus
- Pharmacogenetics of Ace Inhibitor-Associated Angioedema
- A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes
- Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105)
- Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy
- Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes
- A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin
- Changes in Bone Turnover With Increased Incretin Hormone Exposure
- A Post Marketing Safety Study of Sitagliptin Phosphate/Metformin Hydrochloride (JANUMET®) (MK-0431A-235)
- An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)
- A Post Marketing Safety Study of Sitagliptin (JANUVIA®) (MK-0431-234)
- Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and Insulin
- Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)
- Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes
- Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases
- Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus
- Metformin and Sitagliptin in Women With Previous Gestational Diabetes
- Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 Diabetes
- Prescription Patterns, Resource Utilization & Costs - Add-on Therapy With Anti Dipeptidyl Peptidase-IVs vs Rosiglitazone
- Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)
- Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes
- Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery
- JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic Patients
- Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes
- Sitagliptin in Cystic Fibrosis-Related Diabetes
- A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients
- Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus
- Effects of Sitagliptin (Januvia®) on Blood Glucose Control in Patients With Type 1 Diabetes
- Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea
- Glycemic Holter Study (Continuous Glucose Monitoring) -
- Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)
- Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant
- START-J: SiTAgliptin in eldeRly Trial in Japan
- Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes
- Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)
- A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy
- Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)
- Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes
- The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)
- Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)
- A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263
- A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics
- The Role of P-glycoprotein in Sitagliptin Clinical Pharmacology
- The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)
- The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)
- A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Sitagliptin When Given Together to Healthy Subjects
- Sitagliptin Versus Insulin Dose Increase in Type 2 Diabetes on Insulin Treatment
- Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin Treatment
- A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.
- Vascular Effects of Sitagliptin in Diabetes Mellitus
- Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes Mellitus
- Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122)
- Dipeptidyl Peptidase-4 Inhibition and Immune Function in HIV
- The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus
- Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone
- The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial
- Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)
- A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)
- Role of Interleukin-6 in Exercise
- Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)
- Januvia Re-examination Study (MK-0431-181)
- Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016)
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and Sitagliptin
- Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin
- Sitagliptin in Prevention of Type 2 Diabetes Mellitus
- Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 Diabetes
- A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)
- 30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064)
- DPP-4 Inhibition and TZD for DM Prevention
- Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin
- Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202)
- Dapagliflozin DPPIV Inhibitor add-on Study
- Assessing Glucose Effects of Sitagliptin (Januvia) in Adult Patients With Type 1 Diabetes
- 24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years
- A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes
- A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED)
- Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes
- Predictive Parameters for Efficacy of Sitagliptin and Metformin Combination
- Effect of Sitagliptin on Endothelial Progenitor Cells
- Prevention of Cystic Fibrosis Diabetes
- Phenotypic and Genetic Correlates of Diabetes (Non-Type 1) in Young Non-Obese Asian Indians in North India and A Study to Evaluate the Efficacy of Sitagliptin (DPP-4 Inhibitor) in a Sub-group of the Study Population
- A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Concomitant Administration of Sitagliptin and Metformin as Individual Tablets (0431A-048)
- A Study to Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095)
- Effect of Sitagliptin in Impaired Glucose Tolerance
- Clinical Trial to Investigate the Pharmacokinetics/Pharmacodynamics of Sitagliptin
- Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment
- Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes Patients
- Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)
- Effect of Sitagliptin on Postprandial Lipoprotein Metabolism
- Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation
- Sitagliptin/Metformin Fed Bioequivalence Study (0431A-080)
- A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)
- A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179)
- Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Hormonal Responses to Macronutrient Ingestion
- Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)
- "Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"
- Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension
- Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (Explores What the Body Does to the Drug), and Pharmacodynamics (Explores What a Drug Does to the Body) of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus
- A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin
- Sitagliptin Umbilical Cord Blood Transplant Study
- Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
- Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes
- Effect of Sitagliptin on Graft Function Following Islet Transplantation
- Evaluation of Insulin Glargine in Combination With Sitagliptin in Type 2 Diabetes Patients: EASIE Extension Trial
- Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism
- Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects
- A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.
- Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes
- Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes
- MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)
- ALPHA Sitagliptin Add on to Metformin (0431-103)
- The Effect of Sitagliptin in Type 2 Diabetes Mellitus With Inadequate Glycemic Control (MK0431-118)
- Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)
- A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110)
- Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM
- A Study to Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074)
- Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals
- Incretin Effect in People With Impaired Fasting Glucose
- Sitagliptin Cardiovascular Outcomes Study (MK-0431-082)
- Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes
- A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Safety, Tolerability, and Pharmacokinecs.
- Response To Oral Agents in Diabetes (ROAD)- Pilot Study
- Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
- Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)
- Incretin Effect and Use After Clinical Islet Transplantation
- Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During Ramadan
- Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus
- Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)
- A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
- Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients
- BI 10773 add-on to Metformin in Patients With Type 2 Diabetes
- How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.
- Sitagliptin in Renal Transplant Recipients
- A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
- Bone Turnover in Type 2 Diabetes Patients
- A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081)
- Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione
- MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)
- Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic Syndrome
- The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients
- Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)
- A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)
- The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus
- Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress
- The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation
- Sitagliptin in Combination With Metformin and Sulfonylurea
- A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin
- Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis
- Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
- Effects of Glutamine on GLP-1 and Insulin Secretion in Man
- Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome
- 18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)
- Effects of Sitagliptin on Postprandial Lipemia in Men With Type 2 Diabetes
- The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic Subjects
- Study of the Effect of Sitagliptin on Glucose (Sugar) Metabolism in Patients With Heart Failure
- Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial Infarction
- An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED)
- An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes
- A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)
- A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)
- Beta-cell Function in Glucose Abnormalities and Acute Myocardial Infarction
- Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency
- Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes Mellitus
- Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)
- Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)
- A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)
- Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)
- MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066)
- Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)
- Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)
- Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)
- Effects of Sitagliptin on Gastric Emptying in Healthy Subjects
- Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin
- A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)
- A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus
- Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant
- Sitagliptin in the Elderly
- Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)
- Ketosis Prone Diabetes in African-Americans
- Effect of Januvia on Beta Cell Function in Patients With Diabetes Mellitus
- Beta-Cell Function and Sitagliptin Trial (BEST)
- A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)
- A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)
- Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 Diabetes
- Initial Combination With Pioglitazone Study (0431-064)
- Sitagliptin Added-on to Insulin Study (0431-051)
- MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)
- Incretins in Impaired Fasting Glucose
- Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)
- Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus
- Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)
- A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)
- MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)
- An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)
- Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)
Clinical trials list
click for details